282 related articles for article (PubMed ID: 27433507)
1. Target Therapy in Hematological Malignances: New Monoclonal Antibodies.
Podhorecka M; Markowicz J; Szymczyk A; Pawlowski J
Int Sch Res Notices; 2014; 2014():701493. PubMed ID: 27433507
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies in hematological malignancies: past, present and future.
Tazi I; Nafil H; Mahmal L
J Cancer Res Ther; 2011; 7(4):399-407. PubMed ID: 22269399
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies in the treatment of hematopoietic malignancies.
Houghton A; Scheinberg D
Semin Hematol; 1988 Jul; 25(3 Suppl 3):23-9. PubMed ID: 3051406
[TBL] [Abstract][Full Text] [Related]
4. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies for the treatment of non-hematological tumors: a safety review.
Corsini LR; Fanale D; Passiglia F; Incorvaia L; Gennusa V; Bazan V; Russo A
Expert Opin Drug Saf; 2018 Dec; 17(12):1197-1209. PubMed ID: 30457416
[No Abstract] [Full Text] [Related]
6. Genetically engineered monoclonal antibodies for direct anti-neoplastic treatment and cancer cell specific delivery of chemotherapeutic agents.
Bodey B; Bodey B; Siegel SE; Kaiser HE
Curr Pharm Des; 2000 Feb; 6(3):261-76. PubMed ID: 10637379
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies in cancer treatment: where do we stand after 10 years?
Boven E; Pinedo HM
Radiother Oncol; 1986 Feb; 5(2):109-17. PubMed ID: 3517970
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies for the treatment of non-haematological tumours: update of an expanding scenario.
Bronte G; Sortino G; Passiglia F; Rizzo S; Lo Vullo F; Galvano A; Bazan V; Rolfo C; Russo A
Expert Opin Biol Ther; 2015 Jan; 15(1):45-59. PubMed ID: 25250872
[TBL] [Abstract][Full Text] [Related]
9. Tumour cell surface antigen targeted therapies in B-cell lymphomas: Beyond rituximab.
Ku M; Chong G; Hawkes EA
Blood Rev; 2017 Jan; 31(1):23-35. PubMed ID: 27568879
[TBL] [Abstract][Full Text] [Related]
10. Treatment with monoclonal antibodies in acute lymphoblastic leukemia: current knowledge and future prospects.
Gökbuget N; Hoelzer D
Ann Hematol; 2004 Apr; 83(4):201-5. PubMed ID: 14648023
[TBL] [Abstract][Full Text] [Related]
11. Combination of chemotherapy and monoclonal antibodies for the treatment of lymphoma.
Thieblemont C; Coiffier B
Int J Hematol; 2002 Dec; 76(5):394-400. PubMed ID: 12512833
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody-based therapies for hematologic malignancies.
Multani PS; Grossbard ML
J Clin Oncol; 1998 Nov; 16(11):3691-710. PubMed ID: 9817291
[TBL] [Abstract][Full Text] [Related]
13. Specificity of monoclonal antibodies directed against human and murine class II histocompatibility antigens as analyzed by binding to HLA-deletion mutant cell lines.
Shaw S; Ziegler A; DeMars R
Hum Immunol; 1985 Apr; 12(4):191-211. PubMed ID: 3921497
[TBL] [Abstract][Full Text] [Related]
14. Localization and imaging of radiolabeled monoclonal antibodies against colorectal carcinoma in tumor-bearing nude mice.
Buchsbaum D; Lloyd R; Juni J; Wollner I; Brubaker P; Hanna D; Spicker J; Burns F; Steplewski Z; Colcher D
Cancer Res; 1988 Aug; 48(15):4324-33. PubMed ID: 3390828
[TBL] [Abstract][Full Text] [Related]
15. Clinical status of monoclonal antibodies in the treatment of colorectal carcinoma.
Mellstedt H; Frodin JE; Masucci G
Oncology (Williston Park); 1989 Dec; 3(12):25-32; discussion 37-9, 42. PubMed ID: 2701408
[TBL] [Abstract][Full Text] [Related]
16. The development and analysis of species specific and cross reactive monoclonal antibodies to leukocyte differentiation antigens and antigens of the major histocompatibility complex for use in the study of the immune system in cattle and other species.
Davis WC; Marusic S; Lewin HA; Splitter GA; Perryman LE; McGuire TC; Gorham JR
Vet Immunol Immunopathol; 1987 Jul; 15(4):337-76. PubMed ID: 3114940
[TBL] [Abstract][Full Text] [Related]
17. Experimental immunotherapy of human breast carcinomas implanted in nude mice with a mixture of monoclonal antibodies against human milk fat globule components.
Ceriani RL; Blank EW; Peterson JA
Cancer Res; 1987 Jan; 47(2):532-40. PubMed ID: 3791239
[TBL] [Abstract][Full Text] [Related]
18. HLA typing with monoclonal antibodies: evaluation of 356 HLA monoclonal antibodies including 181 studied during the 10th International Histocompatibility Workshop.
Colombani J; Lepage V; Raffoux C; Colombani M
Tissue Antigens; 1989 Aug; 34(2):97-110. PubMed ID: 2609328
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody technology.
Tami JA; Parr MD; Brown SA; Thompson JS
Am J Hosp Pharm; 1986 Nov; 43(11):2816-25. PubMed ID: 3541584
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies: the promise and the reality.
Coons T
Radiol Technol; 1995; 67(1):39-60; quiz 61-4. PubMed ID: 7491408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
